Clinical Differences of EGFR Mutations in Exon 19 and 21 in Clinical Course of Non-Small Cell Lung Cancer Patients

被引：0
|
作者：
Jang, Tae Won [1 ]
Jung, Maanhong [1 ]
Oak, Chul H. [1 ]
Nam, Sung J. [1 ]
机构：
[1] Univ Med Coll, Pusan, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
lung cancer; Prognostic factors; Epidermal growth factor receptor;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.01-020
引用
收藏
页码：S528 / S528
页数：1
相关论文
共 50 条
  • [21] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Simon Vyse
    Paul H. Huang
    Signal Transduction and Targeted Therapy, 4
  • [22] Targeting EGFR exon 20 insertion mutations in non-small cell lung cancer
    Vyse, Simon
    Huang, Paul H.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2019, 4 (1)
  • [23] Clinical features reflect exon sites of EGFR mutations in patients with resected non-small-cell lung cancer
    Na, Im Il
    Rho, Jin Kyung
    Choi, Yun Jung
    Kim, Cheol Hyeon
    Koh, Jae Soo
    Ryoo, Baek-Yeol
    Yang, Sung Hyun
    Lee, Jae Cheol
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (03) : 393 - 399
  • [24] Clinical Outcomes in Non-Small Cell Lung Cancers Harboring Different Exon 19 Deletions in EGFR
    Chung, Kuei-Pin
    Wu, Shang-Gin
    Wu, Jenn-Yu
    Yang, James Chih-Hsin
    Yu, Chong-Jen
    Wei, Pin-Fei
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    CLINICAL CANCER RESEARCH, 2012, 18 (12) : 3470 - 3477
  • [25] Validation of PNA-LNA PCR clamp assay for detection of EGFR exon 19 and 21 mutations in various types of clinical non-small cell lung cancer specimens
    Skronski, Michal
    Jagus, Paulina
    Langfort, Renata
    Szpechcinski, Adam
    Maszkowska-Kopij, Krystyna
    Roszkowska-Sliz, Barbara
    Grudny, Jacek
    Zaleska, Jolanta
    Orlowski, Tadeusz
    Roszkowski-Sliz, Kazimierz
    Chorostowska-Wynimko, Joanna
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [26] Association between EGFR exon 19 or exon 21 mutations and survival rates after first-line EGFR-TKI treatment in patients with non-small cell lung cancer
    Jiang, Haiying
    Zhu, Mei
    Li, Yanfang
    Li, Qian
    MOLECULAR AND CLINICAL ONCOLOGY, 2019, 11 (03) : 301 - 308
  • [27] Genomic profiling reveals non-small cell lung cancer with common mutations of EGFR exon 20 and exon 21: a case report
    Bi, Xiaojun
    Song, Pengyu
    Wang, Chengye
    Zhang, Xuefei
    Liu, Changhong
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (05) : 1423 - 1428
  • [28] DETECTING EGFR MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER
    Hammoudeh, Z. A.
    Antonova, O.
    Staneva, R.
    Nikolova, D.
    Kyuchukov, Y.
    Penev, A.
    Mintchev, T.
    Koleva, V
    Hadjidekova, S.
    Toncheva, D.
    BALKAN JOURNAL OF MEDICAL GENETICS, 2018, 21 (01) : 13 - 17
  • [29] Comparison of clinical outcome between gefitinib and erlotinib treatment in patients with non-small cell lung cancer harboring an epidermal growth factor receptor exon 19 or exon 21 mutations
    Lim, Sung Hee
    Lee, Ji Yoon
    Sun, Jong-Mu
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [30] COMPARISON OF CLINICAL OUTCOME BETWEEN GEFITINIB AND ERLOTINIB TREATMENT IN PATIENTS WITH NON-SMALL CELL LUNG CANCER HARBORING AN EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 OR EXON 21 MUTATIONS
    Lim, Sung Hee
    Lee, Ji Yun
    Kim, Moonjin
    Kim, Sungmin
    Jung, Hyunae
    Chang, Won Jin
    Choi, Moon Ki
    Sun, Jong-Mu
    Hong, Jung Yong
    Lee, Su Jin
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1204 - S1205
12345